Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

InParanoid 7: new algorithms and tools for eukaryotic orthology analysis.

Ostlund G, Schmitt T, Forslund K, Köstler T, Messina DN, Roopra S, Frings O, Sonnhammer EL.

Nucleic Acids Res. 2010 Jan;38(Database issue):D196-203. doi: 10.1093/nar/gkp931.

2.

Parathyroid hormone accelerates decompensation following left ventricular hypertrophy.

Cha H, Jeong HJ, Jang SP, Kim JY, Yang DK, Oh JG, Park WJ.

Exp Mol Med. 2010 Jan 31;42(1):61-8. doi: 10.3858/emm.2010.42.1.006.

3.

Next generation software for functional trend analysis.

Berriz GF, Beaver JE, Cenik C, Tasan M, Roth FP.

Bioinformatics. 2009 Nov 15;25(22):3043-4. doi: 10.1093/bioinformatics/btp498.

4.

Myofibrillogenesis in the developing zebrafish heart: A functional study of tnnt2.

Huang W, Zhang R, Xu X.

Dev Biol. 2009 Jul 15;331(2):237-49. doi: 10.1016/j.ydbio.2009.04.039.

5.

Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.

Granata R, Trovato L, Gallo MP, Destefanis S, Settanni F, Scarlatti F, Brero A, Ramella R, Volante M, Isgaard J, Levi R, Papotti M, Alloatti G, Ghigo E.

Cardiovasc Res. 2009 Jul 15;83(2):303-12. doi: 10.1093/cvr/cvp090.

6.

Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.

Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, Willerson JT, Betocchi S, Wickline SA, Efimov IR, Marian AJ.

Circulation. 2009 Mar 17;119(10):1398-407. doi: 10.1161/CIRCULATIONAHA.108.790501.

7.

Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Baudenbacher F, Schober T, Pinto JR, Sidorov VY, Hilliard F, Solaro RJ, Potter JD, Knollmann BC.

J Clin Invest. 2008 Dec;118(12):3893-903. doi: 10.1172/JCI36642.

8.

The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.

Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K, Tinney JP, Moskowitz IP, Perez-Atayde AR, Keller BB, Mathier MA, Shroff SG, Seidman CE, Seidman JG.

PLoS One. 2008 Jul 9;3(7):e2642. doi: 10.1371/journal.pone.0002642.

9.

Diurnal profiling of neuroendocrine genes in murine heart, and shift in proopiomelanocortin gene expression with pressure-overload cardiac hypertrophy.

Chalmers JA, Lin SY, Martino TA, Arab S, Liu P, Husain M, Sole MJ, Belsham DD.

J Mol Endocrinol. 2008 Sep;41(3):117-24. doi: 10.1677/JME-08-0050.

10.

RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse.

Wagner KD, Wagner N, Ghanbarian H, Grandjean V, Gounon P, Cuzin F, Rassoulzadegan M.

Dev Cell. 2008 Jun;14(6):962-9. doi: 10.1016/j.devcel.2008.03.009.

11.

fdrtool: a versatile R package for estimating local and tail area-based false discovery rates.

Strimmer K.

Bioinformatics. 2008 Jun 15;24(12):1461-2. doi: 10.1093/bioinformatics/btn209.

12.

The Zebrafish Information Network: the zebrafish model organism database provides expanded support for genotypes and phenotypes.

Sprague J, Bayraktaroglu L, Bradford Y, Conlin T, Dunn N, Fashena D, Frazer K, Haendel M, Howe DG, Knight J, Mani P, Moxon SA, Pich C, Ramachandran S, Schaper K, Segerdell E, Shao X, Singer A, Song P, Sprunger B, Van Slyke CE, Westerfield M.

Nucleic Acids Res. 2008 Jan;36(Database issue):D768-72.

13.

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.

Alcalai R, Seidman JG, Seidman CE.

J Cardiovasc Electrophysiol. 2008 Jan;19(1):104-10. Review.

PMID:
17916152
14.

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG.

J Clin Invest. 2007 Jul;117(7):1814-23.

15.

Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy.

Kim JB, Porreca GJ, Song L, Greenway SC, Gorham JM, Church GM, Seidman CE, Seidman JG.

Science. 2007 Jun 8;316(5830):1481-4.

16.

Cardiac myocyte cell cycle control in development, disease, and regeneration.

Ahuja P, Sdek P, MacLellan WR.

Physiol Rev. 2007 Apr;87(2):521-44. Review.

17.

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.

Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ.

Circulation. 2006 Jul 18;114(3):216-25.

18.

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.

Wolf CM, Moskowitz IP, Arno S, Branco DM, Semsarian C, Bernstein SA, Peterson M, Maida M, Morley GE, Fishman G, Berul CI, Seidman CE, Seidman JG.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18123-8.

19.

Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice.

Yoshida M, Minamisawa S, Shimura M, Komazaki S, Kume H, Zhang M, Matsumura K, Nishi M, Saito M, Saeki Y, Ishikawa Y, Yanagisawa T, Takeshima H.

J Biol Chem. 2005 Feb 4;280(5):3500-6.

20.

Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.

Kubalova Z, Györke I, Terentyeva R, Viatchenko-Karpinski S, Terentyev D, Williams SC, Györke S.

J Physiol. 2004 Dec 1;561(Pt 2):515-24.

Items per page

Supplemental Content

Support Center